| Bioactivity | Ferroptosis-IN-6 (compound 13) is a potent inhibitor of Ferroptosis with EC50 of 25.5 nM. Ferroptosis-IN-6 significantly inhibits RSL3-induced cell death in cells and in vivo[1]. | ||||||||||||
| Name | Ferroptosis-IN-6 | ||||||||||||
| CAS | 1517780-59-4 | ||||||||||||
| Formula | C15H17NO | ||||||||||||
| Molar Mass | 227.30 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Sheng XH, et al. Design, synthesis, and biological evaluation of 2-amino-6-methyl-phenol derivatives targeting lipid peroxidation with potent anti-ferroptotic activities. Eur J Med Chem. 2023 Nov 28;264:115997. |
Ferroptosis-IN-6
CAS: 1517780-59-4 F: C15H17NO W: 227.30
Ferroptosis-IN-6 (compound 13) is a potent inhibitor of Ferroptosis with EC50 of 25.5 nM. Ferroptosis-IN-6 significantly
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.